Abstract
Mixed epithelial-stromal tumours (MESTs) are a rare biphasic tumour that frequently arise in women from the renal and urogenital tract. They are also seen in men but are exceptionally uncommon with only few cases reported to originate from the seminal vesicles. Malignant transformation of its epithelial or stromal components is possible; however, by in large, these tumours are benign in nature. We report the case of a 48-year-old man with no remarkable medical or surgical history who presented with a huge expanding pelvic and intra-abdominal mass that required extensive surgical management including a pelvic exenteration. Histopathological analysis concluded the diagnosis of benign MEST originating from the seminal vesicles with no malignant features. No further systemic therapy was recommended for our patient. Given the technical intricacy in the operative resection of this tumour, we aim to present our findings and surgical management of this complex MEST.
Keywords: mixed epithelial-stromal tumours, massive, seminal vesicle, tumour, resection
Introduction
Mixed epithelial-stromal tumours (MESTs) are a rare and mostly benign neoplasm that arise commonly from the urogenital tract [1]. MESTs are often diagnosed in perimenopausal women and can vary in size, with literature describing ranges between 2.5 and 29 cm [2]. The pathogenesis of MEST of seminal vesicles is unknown; however, there has been growing evidence of its relationship with progesterone and oestrogen exposure as well as a genetic basis for its disease [3]. Here, we report a case of MEST in a middle-aged man with a significant tumour burden in his pelvic and abdominal cavity, requiring extensive surgical resection through intraperitoneal, extraperitoneal, and perineal approaches to achieve clear margins via pelvic exenteration.
Case report
A 48-year-old man with 6 months of worsening abdominal distension was referred with a diagnostic abdominal Computed Tomography (CT) scan revealing a large mass in his abdomen and pelvis. He reported no urinary or faecal obstructive symptoms, vomiting, loss of appetite, or any positional or exertional dyspnoea. There was no relevant personal or familial medial history and no previous abdominal surgeries. On examination, his abdomen was markedly distended (Fig. 1) with a palpable non-tender soft mass extending from the xiphoid process to the pubic symphysis.
His full blood count, biochemistry, inflammatory, and tumour markers were within the normal range. The CT scan revealed a large pelvic extraperitoneal mass displacing bowels with heterogenous enhancing solid and non-enhancing cystic components (Fig. 2C). MRI evaluation of the pelvis showed a heterogenous and hyperintense lesion with internal septation and cystic changes invading the pelvic floor (Fig. 2A, B).
An incisional biopsy was performed via a mini-laparotomy, which reported an initial diagnosis of angiomyofibroblastoma.
The patient underwent an elective laparotomy, which showcased a very large abdominal mass (Fig. 3A). Initial intra-operative examination revealed a smooth, well encapsulated mass that mobilized up in the upper abdomen. However, in the lower abdomen, intraperitoneal and pelvic dissection of the tumour was hampered by dense adherence to the rectum, bladder, and distal ureters with obliteration of dissection planes. Thus, an extraperitoneal approach to the pelvic viscera was commenced but the gross involvement of the bladder musculature along with the need to take the pelvic visceral vessels mandated a cysto-prostatectomy. Due to extensive disruption by tumour of the pelvic floor and the rectal involvement, there was little possibility for restoration of gastrointestinal continuity hence an abdominoperineal excision of the rectum was performed to achieve complete tumour-free resection. An ileal conduit was constructed, and end colostomy was performed.
The resected tumour measured 65 cm × 36 cm × 9 cm and weighed 8.08 kg. There was a well demarcated outer capsule (Fig. 3C). The tumour surface was smooth, homogenous with observable extensive capillary networks and contained no signs of infection or necrosis.
Histopathology reported a biphasic tumour comprised an epithelial surface (Fig. 4B) with cystic and glandular structures and no signs of atypia along with a stromal component (Fig. 4C) containing uniform spindle cells. Discussions with the examining pathologist favoured the tumour to have originated from the seminal vesicles given its composition and proximity (Fig. 4A). A phyllodes-like pattern was also seen (Fig. 4D).
Immunohistochemistry of the stroma showed positive staining for oestrogen, progesterone, desmin, and smooth muscle actin. The glandular component was cytokeratin positive with intact basal cells and stained negative for prostate markers (Prostate-Specific Antigen, Prostate Specific Acid Phosphatase, NKX3.1).
Post-surgery the patient remained well and was discharged 2 weeks later with planned radiological follow-up.
Discussion
MESTs are a rare soft-tissue tumour that commonly arise from the urogenital tract with biological behaviours ranging from benign to malignant [4].
MEST typically affects perimenopausal women with a preference to involve renal parenchyma. In males, it is exceptionally rare and is associated with a history of hormonal therapy (androgen deprivation/oestrogen therapy) often coupled with managing prostate cancer [5].
MEST occurrence in the SV is very rare. A recent systematic review by Babar et al. [6] reported only 36 cases of MEST SV in the English literature with varying presenting complaints ranging from asymptomatic, urinary retention, haematuria, and abdominal pain. MESTs were originally described in 1944 by Plautt et al. [7] who reported a large 15 cm abdominal mass originating from the seminal vesicles and initially termed this cystomyoma, due to the biphasic epithelial and stromal components. Subsequent reports included different nomenclatures such as cystadenoma, papillary cystadenoma, mullerian adenosarcoma-like tumour, Phyllodes tumour, and benign fibroepithelial tumour [1, 8]. Complementing a recent review by Reikie et al. [9], the World Health Organisation has reported clear criteria for diagnosis of MEST [10] proposing a common terminology (MEST), to designate the tumours of the seminal vesicle that contain both epithelial and stromal components.
Malignant MESTs have been described using a three-tiered grading system (low/intermediate/high) based on stromal atypia, mitotic activity, pleomorphism, and necrosis [11, 12]. Within the literature, up to 94% of all MESTs of SV are low-grade, and, regardless of size, there are no reports of metastasis and although local recurrence is possible, these tumours have generally good prognosis [6]. Malignant transformation of MEST is possible and indicates poorer outcomes [13].
MEST diagnosis heavily depends on histopathology as tumours of the pelvic/urogenital tract can have multiple aetiologies and, even with sophisticated imaging modalities, clear differentiation can be difficult [4, 14].
Interestingly, our initial biopsy of the tumour was favoured to represent a myofibroblastic lesion such as an angiomyofibroblastoma or cellular angiofibroma due to the biopsy only containing stromal component. However, upon reviewing the entire resected specimen, both stromal and epithelial components were present, which fits well with MEST of SV.
Differentiating benign from malignant MEST is important, with the former commonly exhibiting stromal blandness and the absence of mitotic activity [12]. Histologically, all MESTs contain hypercellular stroma consisting of spindle cells interspersed between glands with immunohistochemical staining revealing diffuse stromal positivity for SMA, desmin, h-caldesmon, oestrogen, and progesterone [2, 4]. More worrisome pathology, such as infiltrative borders, cell atypia, increased mitotic activity, haemorrhage, and necrosis, are associated with malignant potential [9].
Therapeutic management is centred on complete surgical resection of tumour-burdened viscera with a systematic review describing resection using open (57%), laparoscopic (26%), or robotic (17%) techniques [6]. Previous case reports have described intraperitoneal excision of smaller tumours laparoscopically [4, 15].
However, the extensive size and involvement of pelvic organs, as seen in our case, has not been reported and highlights the need for adequate imaging and preparation for extensive pelvic organ dissection, and where required, as we found, resection of those organs to obtain a complete resection of the tumour.
Conclusion
We report a very rare benign tumour of the seminal vesicles that presented with a massive abdominal component emanating from the locally advanced pelvic component. To achieve complete resection, the man required a pelvic exenteration. The prognosis from this extensive benign tumour should be excellent.
Acknowledgements
We would like to acknowledge and express our gratitude to the Colorectal, Upper Gastrointestinal, and Urological Surgical departments at the Princess Alexandra Hospital for their involvement and expertise in this case.
Contributor Information
Zirong Yu, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Kay Tai Choy, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Ferdinand Ong, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Evan Williams, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Sanjeev Naidu, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Bernard M Smithers, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Anjan Gurung, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia; Department of Anatomical Pathology at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Nicholas Lutton, Department of General Surgery at Princess Alexandra Hospital-199 Ipswich Rd, Woolloongabba, QLD 4102, Australia.
Conflict of interest statement
None declared. Corresponding author is not a recipient of research scholarship or other affiliations.
Funding
None declared.
Data availability
The data that support the findings of this study are available from the corresponding author, ZY, upon reasonable request.
References
- 1. Monica B, Larosa M, Facchini F, et al. Low grade epithelial stromal tumour of the seminal vesicle. World J Surg Oncol 2008;6:101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Thway K, Freeman A, Woodhouse CRJ, et al. Epithelial-stromal tumor of seminal vesicle in a patient with chromophobe renal cell carcinoma and small lymphocytic lymphoma. Ann Diagn Pathol 2008;12:433–9. [DOI] [PubMed] [Google Scholar]
- 3. Son HJ, Jeong YJ, Kim JH, et al. Phyllodes tumor of the seminal vesicle: case report and literature review. Pathol Int 2004;54:924–9. [DOI] [PubMed] [Google Scholar]
- 4. Debnath A, Cheriyan A, Daniel S, et al. Laparoscopic resection of a large mixed epithelial-stromal tumour of the seminal vesicle: a rare entity and review of the current literature. BMJ Case Rep 2021;14:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Colombo P, Naspro R, Vallieri L, et al. Non-hormone-induced mixed epithelial and stromal tumor of kidney in a man: description of a rare case. Urology 2008;71:168.e7–9. [DOI] [PubMed] [Google Scholar]
- 6. Babar M, Matloubieh J, Macdonald E, et al. Diagnosis and treatment of a mixed epithelial stromal tumor of the seminal vesicle: a systematic review. Urology 2022;167:13–8. [DOI] [PubMed] [Google Scholar]
- 7. Plaut A, Standard S. Cystomyoma of seminal vesicle. Ann Surg 1944;119:253–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Mazur MT, Myers JL, Maddox WA. Cystic epithelial-stromal tumor of the seminal vesicle. Am J Surg Pathol 1987;11:210–7. [DOI] [PubMed] [Google Scholar]
- 9. Reikie BA, Yilmaz A, Medlicott S, et al. Mixed Epithelial-Stromal Tumor (MEST) of seminal vesicle: a proposal for unified nomenclature. Adv Anat Pathol 2015;22:113–20. [DOI] [PubMed] [Google Scholar]
- 10. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. Eur Urol 2016;70:93–105. [DOI] [PubMed] [Google Scholar]
- 11. Baschinsky DY, Niemann TH, Maximo CB, et al. Seminal vesicle cystadenoma: a case report and literature review. Urology 1998;51:840–5. [DOI] [PubMed] [Google Scholar]
- 12. Eble J. World Health Organization classification of tumours. In: Eble JN, Sauter G, Epstein J, S esterhenn I (eds). Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer (IARC), Lyon, France. 2004, 68–9.
- 13. Abe H, Nishimura T, Miura T, et al. Cystosarcoma phyllodes of the seminal vesicle. Int J Urol 2002;9:599–601. [DOI] [PubMed] [Google Scholar]
- 14. Kim B, Kawashima A, Ryu JA, et al. Imaging of the seminal vesicle and vas deferens. Radiographics 2009;29:1105–21. [DOI] [PubMed] [Google Scholar]
- 15. Khan MS, Zaheer L-U, Ahmed K, et al. Low-grade phyllodes tumor of the seminal vesicle treated with laparoscopic excision. Nat Clin Pract Urol 2007;4:395–400. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author, ZY, upon reasonable request.